Literature DB >> 26453147

Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.

Jean-Winoc Decousser1, Marine Desroches2, Nadège Bourgeois-Nicolaos3, Julien Potier4, François Jehl5, Gérard Lina6, Vincent Cattoir7, François Vandenesh6, Florence Doucet-Populaire3.   

Abstract

Multiresistance in staphylococci constitutes a major challenge for the antimicrobial chemotherapy of invasive infections such as bacteraemia or bone and joint infections (BJIs). A nationwide prospective study was performed to detect antimicrobial resistance trends among staphylococci causing invasive infections. Between October 2011 and February 2012, 367 meticillin-resistant Staphylococcus aureus (MRSA) and 695 coagulase-negative staphylococci (CoNS) were collected from 37 French hospitals, mainly from bacteraemia (59.9%) and osteoarticular infections (29.0%). Minimum inhibitory concentrations (MICs) were determined by broth microdilution, and specific screening and confirmation tests were performed to detect heterogeneous vancomycin-intermediate S. aureus (hVISA). Staphylococcal isolates exhibiting a linezolid MIC>4 mg/L were further characterised to determinate their clonal relationships and the mechanism of resistance. MRSA exhibited additional resistances, including levofloxacin (82% associated resistance), gentamicin (13.6%), fusidic acid (13.6%) and rifampicin (6.5%), compromising oral step-down therapy in BJIs. Only two hVISA strains (0.5%) were identified. Among the CoNS, mainly Staphylococcus epidermidis (506/695; 72.8%), resistance to first- and second-line agents was more common. Linezolid resistance was identified in 10 CoNS (1.4%). The most frequent linezolid resistance mechanism was the G2576T mutation in 23S rDNA (9/10). For the first time in France, the cfr gene was found in five related sequence type 2 (ST2) S. epidermidis from two different hospitals, in association with ribosomal RNA and L3 ribosomal protein mutations. These national data must be considered when selecting empirical treatment for invasive staphylococcal infections. Moreover, the emergence and spread of linezolid-resistant CoNS carrying the cfr gene is of concern.
Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Bloodstream; Daptomycin; Linezolid; Osteoarticular; Resistance; Staphylococci

Mesh:

Substances:

Year:  2015        PMID: 26453147     DOI: 10.1016/j.ijantimicag.2015.07.022

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  18 in total

1.  Deletion of One 23S rRNA Gene (rrl) Copy Contributes to the Development of Linezolid Resistance in Staphylococcus warneri.

Authors:  Caroline Rouard; Florence Doucet-Populaire; Christelle Guillet-Caruba; Millie Villet; Nadège Bourgeois-Nicolaos
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 2.  Epidemiology of antimicrobial resistance in bloodstream infections.

Authors:  Murat Akova
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

3.  Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models.

Authors:  Kamilia Abdelraouf; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

4.  Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant.

Authors:  S Albac; D Labrousse; D Hayez; N Anzala; D Bonnot; P Chavanet; E Aslangul; D Croisier
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

5.  Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections.

Authors:  J Lourtet-Hascoët; M P Félicé; A Bicart-See; A Bouige; G Giordano; E Bonnet
Journal:  Epidemiol Infect       Date:  2018-06-08       Impact factor: 4.434

6.  [Current practice of empiric antibiotic treatment for spondylodiscitis].

Authors:  Siegmund Lang; Nike Walter; Carsten Neumann; Susanne Bärtl; Michaela Simon; Martin Ehrenschwender; Florian Hitzenbichler; Volker Alt; Markus Rupp
Journal:  Orthopadie (Heidelb)       Date:  2022-04-07

7.  Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.

Authors:  Ara Jo; Juhee Ahn
Journal:  BMC Microbiol       Date:  2016-07-29       Impact factor: 3.605

8.  Preventing Data Ambiguity in Infectious Diseases with Four-Dimensional and Personalized Evaluations.

Authors:  Michelle J Iandiorio; Jeanne M Fair; Stylianos Chatzipanagiotou; Anastasios Ioannidis; Eleftheria Trikka-Graphakos; Nikoletta Charalampaki; Christina Sereti; George P Tegos; Almira L Hoogesteijn; Ariel L Rivas
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

9.  Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.

Authors:  Koichi Yamada; Hiroki Namikawa; Hiroki Fujimoto; Kiyotaka Nakaie; Etsuko Takizawa; Yasuyo Okada; Akiko Fujita; Hiroyoshi Kawaguchi; Yasutaka Nakamura; Junko Abe; Yukihiro Kaneko; Hiroshi Kakeya
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

10.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.